The bioinformatic analysis identified that LEPROTL1 was highly expressed in pancreatic cancer compared to matched normal pancreatic tissue of the same patients, suggesting a potential involvement in the etiopathology of PDAC. The gene discussed is LEPROTL1; the disease is pancreatic neoplasm.